Dr Caitlin Filby is an experienced stem cell and molecular biologist and physiologist with expertise in development, stem cells, cancer and disease. She is highly trained in culture, isolation and identification of primary epithelial stem cells (from humans and mice) and has developed novel stem cell tools that will increase our understanding of the pathogenesis of endometriosis and will lead to novel precision diagnostic and therapeutic options for endometriosis.

 

Dr Caitlin Filby obtained her PhD at Monash University and completed postdoctoral training at Walter and Eliza Hall Institute of Medical Research and Murdoch Childrens Research Institute.  Dr Filby recently joined Hudson Institute of Medical Research to investigate the pathogenesis of endometriosis. Her long-term career goal is to be an internationally-recognized endometriosis researcher who translates scientific discoveries into improved patient outcomes. She is passionate about endometriosis research and equal opportunities for women.

 

She is a named investigator on a US Dept. of Defence-funded collaborative grant and has received her own funding from EndoFound. In her new field she is recognised as an emerging leader through her appointment as Biobank working group and Secretary of the National Endometriosis Scientific and Clinical Trials Network, an invited review for Seminars in Reproductive Medicine, oral presentation at World Congress on Endometriosis, invited oral presentation at the Society for Reproductive Biology Endometriosis Satellite and selection for the VESKI Inspiring Women in STEM: Side By Side Program.

Selected publications

  • Filby CE, Rombauts L, Montgomery GW, Giudice LC, Gargett CE (2020) Cellular Origins of Endometriosis: Towards Novel Diagnostics and Therapeutics. Semin Reprod Med. 38(2-03):201-215. doi: 10.1055/s-0040-1713429. Epub  PMID: 33176364

  • Lucciola R, Vrljicak P, Gurung S, Filby C, Darzi S, Muter J, Ott S, Brosens JJ, Gargett CE (2020) Impact of Sustained Transforming Growth Factor-β Receptor Inhibition on Chromatin Accessibility and Gene Expression in Cultured Human Endometrial MSC. Front Cell Dev Biol. 8:567610. doi: 10.3389/fcell.2020.567610. PMID: 32984350; PMCID: PMC7490520.

  • Holik AZ, Filby CE, Pasquet J, Viitaniemi K, Ciciulla J, Sutherland KD, Asselin-Labat ML (2015) The LIM-domain only protein 4 contributes to lung epithelial cell proliferation but is not essential for tumor progression. Respir Res. 16(1):67. doi: 10.1186/s12931-015-0228-0. PMID: 26048572; PMCID: PMC4475329.

  • Asselin-Labat ML, Filby CE (2012) Adult lung stem cells and their contribution to lung tumourigenesis. Open Biol. 2(8):120094. doi: 10.1098/rsob.120094. PMID: 22977734; PMCID: PMC3438537.